Michael Loschi

3.5k citations
91 papers · 2.5k · 3 hit papers · h-index 23

Impact in

  • Hematology top 2%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
  • Immunology top 5%
    • T-cell and B-cell Immunology
    • Complement system in diseases

Papers in

    • Hematopoietic Stem Cell Transplantation 31
    • Acute Myeloid Leukemia Research 15
    • CAR-T cell therapy research 15

Michael Loschi

83 papers receiving 2.4k citations

Michael Loschi's Hit Papers

Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study 2023 · 146 citations
1460+1+3Years since publication100200300

Peers

Michael Loschi
Comparison fields: 5 of 79
  • Hematology 714
  • Immunology 576
  • Oncology 629
  • Genetics 143
  • Cancer Research 127
Replace Defu Zeng with:
Defu Zeng United States
Sumithira Vasu United States
Kaoru Uchimaru Japan
Federico Campigotto United States
Eric Van Den Neste Belgium
Koiti Inokuchi Japan
Anna Gayà Spain
Stefania Paolini Italy
Claudio Cerchione Italy
Hong Zheng United States
Michael Loschi relative to Defu Zeng United States Defu Zeng's profile →
Citations per field
00.5×2×3.2×
Defu Zeng · 1×
Citations per year

Countries citing papers authored by Michael Loschi

Since Specialization
Citations

This map shows the geographic impact of Michael Loschi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Loschi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Loschi more than expected).

Fields of papers citing papers by Michael Loschi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Loschi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Loschi. The network helps show where Michael Loschi may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Loschi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Loschi Line = papers co-authored together Michael Loschi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2019356
2
A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma
Hit paper breakdown →
2022303
3
Eprenetapopt Plus Azacitidine in TP53 -Mutated Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Phase II Study by the Groupe Francophone des Myélodysplasies (GFM)
Hit paper breakdown →
2021227
4
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
Hit paper breakdown →
2023146
5 2017134
6 2015121
7 202187
8 201865
9 201962
10 202162
11 202359
12 202252
13 201850
14 201849
15 202448
16 202341
17 201839
18 202337
19 202135
20 202232

About Michael Loschi

Michael Loschi is a scholar working on Hematology, Oncology, Immunology, Genetics and Pathology and Forensic Medicine, having authored 91 papers that have together received 2.5k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (31 papers), Acute Myeloid Leukemia Research (15 papers), CAR-T cell therapy research (15 papers), T-cell and B-cell Immunology (10 papers), Lymphoma Diagnosis and Treatment (5 papers), Blood disorders and treatments (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Complement system in diseases (3 papers). The work is most often cited by research in Hematology (714 citations), Immunology (576 citations), Oncology (629 citations), Genetics (143 citations) and Cancer Research (127 citations). Michael Loschi has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Bruce R. Blazar, Keli Lee Hippen, Govindarajan Thangavelu, Cameron S. Field, Katarzyna M. Grzes, Erika L. Pearce, Daniel J. Puleston, Joy Edwards-Hicks, Francesc Baixauli and Alanna M. Cameron. Their work appears in journals such as Blood, Bone Marrow Transplantation, Blood Advances, Leukemia Research and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact